Actively Recruiting
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Led by Boston Children's Hospital · Updated on 2026-02-11
20000
Participants Needed
1
Research Sites
1352 weeks
Total Duration
On this page
Sponsors
B
Boston Children's Hospital
Lead Sponsor
H
Howard Hughes Medical Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
CONDITIONS
Official Title
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals with congenital conditions related to eye movement, cranial nerve, and brainstem dysfunction, often called congenital cranial dysinnervation disorders (CCDDs).
You will not qualify if you...
- Individuals with cranial nerve disorders linked to known genetic syndromes such as Saethre-Chotzen syndrome.
- Individuals with acquired cranial nerve disorders due to trauma, stroke, tumor, or spinal cord injuries.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
B
Brenda J Barry, MS
CONTACT
E
Engle Admin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here